<DOC>
	<DOCNO>NCT00953667</DOCNO>
	<brief_summary>The purpose study determine genetic factor affect response niacin therapy endotoxemia healthy volunteer .</brief_summary>
	<brief_title>The Genetics Evoked Responses Niacin Endotoxemia : The GENE Study</brief_title>
	<detailed_description>Niacin vitamin beneficial effect cholesterol ( type fat blood ) use high dos . Different people respond differently cholesterol lower dos niacin , people side effect term flushing ( similar hot flash ) others people pronounced effect cholesterol . Endotoxin lipopolysaccharide ( LPS ) small part bacteria ( longer live ) cause many effect similar bacterial infection human . However , administer small amount produce mild inflammatory response much 'flu-like '' illness . Within 1 ½ -3 hour give LPS vein , response consist fever , chill , headache , nausea vomit generalized ache pain occur last 6-8 hour . In addition flu like symptom , inflammation cause change cholesterol , triglyceride glucose clearance . Different people respond differently endotoxin inflammation . We perform study see genetic factor predict people respond niacin endotoxin inflammatory response .</detailed_description>
	<mesh_term>Endotoxemia</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>1 . Men nonpregnant/lactating woman age 18 45 . 2 . Self report African American Caucasian racialethnic background . 3 . Body Mass Index ( BMI ) ≥ 18 ≤ 30 . 4 . Participants able give write informed consent willing comply studyrelated procedure . 1 . Known clinically manifest atherosclerotic cardiovascular disease , include coronary disease , cerebrovascular disease , peripheral vascular disease . 2 . History diabetes mellitus . 3 . Fasting glucose &gt; 126 mg/dL . 4 . History nonskin malignancy within previous 5 year . 5 . Renal insufficiency define creatinine &gt; 1.5 mg/dl Screening Visit . 6 . History liver disease abnormal liver function test ( LFTs ) ( AST , ALT , Alk . Phos. , GGT &gt; 1.5x upper limit normal ( ULN ) ; bilirubin &gt; 2x ULN ) Screening Visit . 7 . Men unwilling limit alcohol consumption &lt; 14 alcoholic drink per week &lt; 4 alcoholic drink per occasion ( AMA / NIAAA criterion `` risk '' usage level ) participate study . 8 . Women unwilling limit alcohol consumption &lt; 7 alcoholic drink per week &lt; 3 alcoholic drink per occasion ( AMA / NIAAA criterion `` risk '' usage level ) participate study . 9 . Total white blood cell count less equal 3.0 THO/uL . 10 . Hemoglobin 11.0 g/dL . 11 . Any major active rheumatologic , pulmonary , dermatologic disease inflammatory condition minor active infection . 12 . History HIV positive . 13 . First degree family history premature cardiovascular disease event ( father brother diagnose 55 year age ; mother sister diagnose 65 year age ) . 14 . Patients undergone organ transplant . 15 . Individuals currently use tobacco product do previous 30 day . 16 . Treatment aspirin , nonsteroidal antiinflammatory drug ( NSAIDs ) , COX2 inhibitor , steroid immunomodulatory therapy 2 week prior Screening Visit . 17 . Treatment statin , fibrates niacin 4 week prior Screening Visit . 18 . Current daily use Vitamin C &gt; 1000 mg , Beta carotene &gt; 1000 IU , vitamin A &gt; 5000 IU , vitamin E &gt; 400 IU , selenium &gt; 200 mcg . 19 . Positive urine pregnancy Screening Visit . 20 . Participation another clinical trial within previous 6 week prior Screening Visit . 21 . Poorly control blood pressure ( BP &gt; 160/110 ) antihypertensive medication . 22 . A diagnosis metabolic syndrome use updated 2004 NCEP ATPIII criterion . 23 . A history severe lactose intolerance ( e.g. , intolerance milk intake ) . 24 . Any medical condition abnormal laboratory value judge clinically significant investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>